| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RASGRP2 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | LILRA2 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | RNF169 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | ANKZF1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | ATP13A1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | CYFIP1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | GLT1D1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | ZFP2 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | PHF20L1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | FAM209A | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
